Funds will allow for advancement of lead molecules and expand its powerful platform for small molecule discovery based on 3D structural analysis of RNA.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

6 Davis Dr.
Durham, NC 27709
USA

Phone

Undisclosed

Website

www.ribometrix.com

Email Address

[email protected]

Overview

A platform therapeutics company discovering small molecule drugs that target functional RNA structures to create new avenues to treat human disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Solomon

Chief Scientific Officer

John Reardon

Founder

Kevin Weeks

Vice President

Donald Hertzog

VP - Bus. Development

Martin Williams

VP - Finance

Jonathan Kearns

VP - Human Resources

Denise Kilpatrick

VP - R & D

Katherine Warner

Browse more venture capital transactions:

Prev: 11/14/2018: Knowtions Research venture capital transaction
Next: 11/14/2018: Heyday Online venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary